Live Breaking News & Updates on Neurosciences Receives Complete Response Letter

Stay updated with breaking news from Neurosciences receives complete response letter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Issues CRL for Roluperidone for Treatment of Negative Symptoms in Schizophrenia

Minerva Neurosciences announced the receipt of a Complete Response Letter for roluperidone in treatment of negative symptoms in patients with schizophrenia on February 27, 2024 despite clinical trial data indicating improved Negative Symptom Factor Scores and Personal and Social Performance scale scores.
....

Remy Luthringer , Minerva Neurosciences , Michael Davidson , Nicosia University Medical School , Minerva Neurosciences Inc , Drug Administration , Complete Response Letter , Negative Symptom Factor Scores , Social Performance , Neurosciences Receives Complete Response Letter , New Drug Application , Negative Symptoms , Us Food And Drug Administration , Food And Drug Administration ,